Active Ingredient(s): Crisaborole
FDA Approved: * December 14, 2016
Pharm Company: * ANACOR PHARMS INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Eucrisa Overview

Crisaborole (trade name Eucrisa) is a nonsteroidal topical medication approved for the treatment of mild-to-moderate atopic dermatitis (eczema) in patients 2 years of age and older.[1][2] As of 2016[update] it is also under development by Anacor Pharmaceuticals for the topical treatment of psoriasis.[3][4][5][6] Contents 1 Mechanism of action 2 Chemistry 3 Clinical trials 4 See also 5 References Mechanism of action It is a phosphodiesterase-4 inhibitor, mainly acting on phosphodie...

Read more Eucrisa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Eucrisa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Ointment: 2%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Eucrisa: (1 result)

Sorted by National Drug Code
  • 55724-211 Eucrisa 20 mg/g Topical Ointment by Anacor Pharmaceuticals, Inc.

Other drugs which contain Crisaborole or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 22 November 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.